drugset / Trial / NCT01698060
Immunogenicity of ND1.1 by Delivery Directly to the Ileum
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of the study is to determine the safety and tolerability of ND1.1, an adjuvanted adenoviral-based avian influenza vaccine, when delivery is targeted to the ileum, using a radio controlled capsule. The secondary objective is to evaluate the immune response (cellular and humoral) of two doses of ND1.1 oral vaccine.
Timeline
- Start
- 2012-09
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ND1.1 | Vaccine | — | Oral |